AR075295A1 - TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION. - Google Patents

TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION.

Info

Publication number
AR075295A1
AR075295A1 ARP090104204A AR075295A1 AR 075295 A1 AR075295 A1 AR 075295A1 AR P090104204 A ARP090104204 A AR P090104204A AR 075295 A1 AR075295 A1 AR 075295A1
Authority
AR
Argentina
Prior art keywords
approximately
hemisulfate
monohidrated
tianeptine
asthma
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Transform Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transform Pharmaceuticals Inc filed Critical Transform Pharmaceuticals Inc
Publication of AR075295A1 publication Critical patent/AR075295A1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

Reivindicacion 1: 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]ácido heptanoico S,S-dioxido hemisulfato monohidratado, representado por la formula (2). Reivindicacion 2: El 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]ácido heptanoico S,S-dioxido hemisulfato monohidratado, de la reivindicacion 1, en forma cristalina. Reivindicacion 11: El 7-[(3-cloro-6,11-dihidro-6-metildibenzo[c,f][1,2]tiazepin-11-il)amino]ácido heptanoico S,S-dioxido hemisulfato monohidratado, de la reivindicacion 1, en donde dicho hemisulfato monohidratado se caracteriza por un difractograma de polvo por rayos X que comprende picos a aproximadamente 8,25, aproximadamente 8,97, aproximadamente 11,49, aproximadamente 13,91, aproximadamente 14,73, aproximadamente 16,95, aproximadamente 18,07, aproximadamente 19,39, aproximadamente 20,59, aproximadamente 21,99, aproximadamente 22,83 y aproximadamente 23,27 grados 2-theta.Claim 1: 7 - [(3-chloro-6,11-dihydro-6-methyldibenzo [c, f] [1,2] thiazepin-11-yl) amino] heptanoic acid S, S-dioxide hemisulfate monohydrate, represented by the formula (2). Claim 2: 7 - [(3-Chloro-6,11-dihydro-6-methyldibenzo [c, f] [1,2] thiazepin-11-yl) amino] heptanoic acid S, S-dioxide hemisulfate monohydrate, of claim 1, in crystalline form. Claim 11: 7 - [(3-Chloro-6,11-dihydro-6-methyldibenzo [c, f] [1,2] thiazepin-11-yl) amino] heptanoic acid S, S-dioxide hemisulfate monohydrate, of Claim 1, wherein said monohydrate hemisulfate is characterized by an X-ray powder diffractogram comprising peaks at approximately 8.25, approximately 8.97, approximately 11.49, approximately 13.91, approximately 14.73, approximately 16 , 95, approximately 18.07, approximately 19.39, approximately 20.59, approximately 21.99, approximately 22.83 and approximately 23.27 degrees 2-theta.

ARP090104204 2008-10-31 2009-10-30 TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION. AR075295A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11000908P 2008-10-31 2008-10-31
US11000608P 2008-10-31 2008-10-31
US11000108P 2008-10-31 2008-10-31
US22834309P 2009-07-24 2009-07-24

Publications (1)

Publication Number Publication Date
AR075295A1 true AR075295A1 (en) 2011-03-23

Family

ID=43447880

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP090104204 AR075295A1 (en) 2008-10-31 2009-10-30 TIANEPTINE MONOHIDRATED HEMISULFATE, PHARMACEUTICAL COMPOSITIONS CONTAINING IT, METHOD TO PREPARE IT AND USE OF IT FOR THE TREATMENT OF ASTHMA AND DEPRESSION.

Country Status (4)

Country Link
AR (1) AR075295A1 (en)
JO (1) JO2844B1 (en)
TW (1) TWI492937B (en)
UY (1) UY32216A (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3758528A (en) * 1970-03-13 1973-09-11 Science Union & Cie Tricyclic compounds
FR2791891A1 (en) * 1999-04-07 2000-10-13 Adir USE OF TIANEPTINE FOR OBTAINING MEDICINES FOR THE TREATMENT OF NEURODEGENERESCENCE CONDITIONS

Also Published As

Publication number Publication date
JO2844B1 (en) 2014-09-15
TW201029981A (en) 2010-08-16
TWI492937B (en) 2015-07-21
UY32216A (en) 2010-05-31

Similar Documents

Publication Publication Date Title
AR068369A1 (en) N4 XINAFOATE SALT - [(2,2-DIFLUOR-4H-BENZO [1,4] OXAZIN-3-ON) -6-IL] -5-FLUOR-N2- [3- (METHYLAMINOCARBONYLMETHYLENE) -FENYL] 2 , 4-PYRIMIDINDIAMINE "
UY32648A (en) NEW DERIVATIVES OF PYRIMIDINE AND ITS USE IN THE TREATMENT OF DISEASES
CL2007001166A1 (en) Compounds derived from condensed pyrimidine, pi3-kinase inhibitors; processes to prepare the compounds; pharmaceutical composition that includes them; use of the compounds in the preparation of medicaments; process to prepare the pharmaceutical composition; and kit that includes the pharmaceutical composition
EA201100969A1 (en) SALT FORMS OF ORGANIC COMPOUND
ECSP10010346A (en) 3H- [1,2,3] TRIAZOLO [4,5-D] PIRIMIDINE COMPOUNDS, THEIR USE AS INHIBITORS OF MTOR QUINASA AND PI3 QUINASA AND THEIR SYNTHESIS
PE20070845A1 (en) PYRAZOLO [1,5-ALPHA] PYRIMIDIN DERIVATIVES USEFUL AS ANTAGONIST RECEPTORS OF CORTICOTROPIN RELEASE FACTOR (CRF)
ECSP11011151A (en) PURINE COMPOUNDS
CL2011002115A1 (en) Compounds derived from 5-phenyl-1h-pyridin-2-one and 5-phenyl-pyrazin-2-one, bruton tyrosine kinase inhibitors (btk); process of preparation of the compounds, intermediate compound, pharmaceutical composition and use in the treatment of inflammatory and / or autoimmune diseases.
CL2008003181A1 (en) 3- [5- (Pyridin-2-yl-methoxy) -3- (2-methyl-2-propylthio) -1- [4- (2-methoxypyridin-5-yl) benzyl] -indol-2 acid salt -yl] -2,2-dimethyl-propionic; crystallin from sodium salt; Preparation process; pharmaceutical compositions; pharmaceutical kit, and use for the treatment of asthma.
UY33337A (en) SUBSTITUTED DERIVATIVES OF 1H-PIRAZOL [3,4-d] PYRIMIDINE AS INHIBITORS OF PHOSFOINOSITIDE 3-KINASES
CL2008000946A1 (en) COMPOUNDS DERIVED FROM PIRROLOPIRIMIDINA, INHIBITORS OF CIANASA JAK3; PREPARATION PROCEDURE; PHARMACEUTICAL COMPOSITION THAT INCLUDES SUCH COMPOUND; AND USE OF THE COMPOUND FOR THE TREATMENT OF REPLACEMENT OF TRANSPLANTS, AUTOIMMUN DISEASES
CO6690744A2 (en) Dry powder formulation comprising a phosphodiesterase inhibitor
MX2009005048A (en) New process for the preparation of 2-imino-thiazolidin-4-one derivatives.
GT201200158A (en) PROCEDURE FOR THE PREPARATION OF {4,6-DIAMINO-2- [1- (2-FLUOROBENCIL) -1H-PIRAZOLO [3,4-B] PIRIDIN-3-IL] PIRIMIDIN-5-IL} METHYL CARBAMATE AND ITS PURIFICATION FOR USE AS A PHARMACEUTICAL ACTIVE PRINCIPLE
CL2012000708A1 (en) Compounds derived from imidazopyridine or imidazopyrimidine, inhibitors of pde10a; process of preparation of said compounds; pharmaceutical compositions; and its use for the therapeutic and / or preventive treatment of psychotic disorders, schizophrenia, Alzheimer's disease, solid tumors, among other diseases.
UY28896A1 (en) POWDER FORMULATIONS FOR INHALATION, WHICH CONTAIN BETA-ENANTIOMERALLY PURE AGONISTS
TW200745122A (en) New compounds I
CU23889B1 (en) 5 - [(3,3,3-TRIFLUORO-2-HIDROXI-1-ARILPROPIL) AMINO] -1H-QUINOLIN-2-ONAS, A PROCESS FOR ITS PRODUCTION AND ITS USE AS ANTINFLAMATORY AGENTS
TW200730511A (en) Chroman compounds
BRPI0408353A (en) compound, pharmaceutical composition, methods for the treatment of susceptible neoplasms and for the treatment of viral infections, and, use of a compound
JO2682B1 (en) 7-ALkynyl-1,8-Naphthyridone Derivatives, Preparation Thereof And Therapeutic Use Thereof
MX2012005225A (en) N-7 substituted purine and pyrazolopyrimidine compounds, compositions and methods of use.
AR116001A2 (en) PHARMACEUTICAL COMPOSITION 271
CU20120081A7 (en) NEW POLYMORPH FORMS OF {4,6-DIAMINO-2- [1- (2-FLUOROBENCIL) -1H-PIRAZOLO [3,4-B] PIRIDIN-3-IL] PIRIMIDIN-5-IL} CARBAMATO DE METTILO
BR112013017757A2 (en) crystalline oxazine derivative and its use as a bace inhibitor

Legal Events

Date Code Title Description
FB Suspension of granting procedure